Antisense oligonucleotides: translation from mouse models to human neurodegenerative diseases
KM Schoch, TM Miller - Neuron, 2017 - cell.com
Multiple neurodegenerative diseases are characterized by single-protein dysfunction and
aggregation. Treatment strategies for these diseases have often targeted downstream …
aggregation. Treatment strategies for these diseases have often targeted downstream …
[HTML][HTML] Antisense oligonucleotides in therapy for neurodegenerative disorders
MM Evers, LJA Toonen… - Advanced drug delivery …, 2015 - Elsevier
Antisense oligonucleotides are synthetic single stranded strings of nucleic acids that bind to
RNA and thereby alter or reduce expression of the target RNA. They can not only reduce …
RNA and thereby alter or reduce expression of the target RNA. They can not only reduce …
Oxidative and nitrative stress in neurodegeneration
CA Cobb, MP Cole - Neurobiology of disease, 2015 - Elsevier
Aerobes require oxygen for metabolism and normal free radical formation. As a result,
maintaining the redox homeostasis is essential for brain cell survival due to their high …
maintaining the redox homeostasis is essential for brain cell survival due to their high …
Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS
Gain-of-function mutations in the Cu, Zn-superoxide dismutase (SOD1) gene are implicated
in progressive motor neuron death and paralysis in one form of inherited amyotrophic lateral …
in progressive motor neuron death and paralysis in one form of inherited amyotrophic lateral …
Lost in translation: treatment trials in the SOD1 mouse and in human ALS
M Benatar - Neurobiology of disease, 2007 - Elsevier
Therapeutic success in the superoxide dismutase (SOD1) mouse model of amyotrophic
lateral sclerosis (ALS) has not translated into effective therapy for human ALS, calling into …
lateral sclerosis (ALS) has not translated into effective therapy for human ALS, calling into …
p75NTR–live or let die
A Nykjaer, TE Willnow, CM Petersen - Current opinion in neurobiology, 2005 - Elsevier
During neuronal development, neurotrophins are essential factors that promote survival,
differentiation and myelination of neurons. The trophic signals are relayed to the cells via …
differentiation and myelination of neurons. The trophic signals are relayed to the cells via …
Therapeutic and diagnostic applications of antisense peptide nucleic acids
V MacLelland, M Kravitz, A Gupta - Molecular Therapy Nucleic Acids, 2024 - cell.com
Peptide nucleic acids (PNAs) are synthetic nucleic acid analogs with a neutral N-(2-
aminoethyl) glycine backbone. PNAs possess unique physicochemical characteristics such …
aminoethyl) glycine backbone. PNAs possess unique physicochemical characteristics such …
A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis
LH Barbeito, M Pehar, P Cassina, MR Vargas… - Brain research …, 2004 - Elsevier
A strong glial reaction typically surrounds the affected upper and lower motor neurons and
degenerating descending tracts of ALS patients. Reactive astrocytes in ALS contain protein …
degenerating descending tracts of ALS patients. Reactive astrocytes in ALS contain protein …
The p75 neurotrophin receptor: at the crossroad of neural repair and death
RB Meeker, KS Williams - Neural regeneration research, 2015 - journals.lww.com
The strong repair and pro-survival functions of neurotrophins at their primary receptors, TrkA,
TrkB and TrkC, have made them attractive candidates for treatment of nervous system injury …
TrkB and TrkC, have made them attractive candidates for treatment of nervous system injury …
Inflammation, Immunity, and amyotrophic lateral sclerosis: I. Etiology and pathology
MS Lyon, M Wosiski‐Kuhn, R Gillespie… - Muscle & …, 2019 - Wiley Online Library
Amyotrophic lateral sclerosis (ALS) is a severely debilitating disease characterized by
progressive degeneration of motor neurons. Charcot first described ALS in 18691; however …
progressive degeneration of motor neurons. Charcot first described ALS in 18691; however …